Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Apr 12, 2007 6:17pm
218 Views
Post# 12597328

Re: Webcast............Dr. Cruz Said

Re: Webcast............Dr. Cruz Said I find this next part of the presentation very intrigueing in that they are Initiating a Stand Alone Phasell Trial with Gastrin (G1) for Typell Diabetes and the Phase1 is done already with zero-nil-nada-No Nausea At All as is commonly found with all the other similar treatments. ---------------------------------------------------------------------- ----We are also developing G1 which is Gastrin alone in Typell Diabetics and also planning a G1 & Byetta, a combination therapy. ----We have already done the Phasel's for Gastrin Alone and there is no Adverse Events at any of the doses there were no adverse events. There is no nausea or nothing of things that are often associated with the other Factors. We plan to do our first Phasell sometime in the 3rd Quarter this year. This is G1 and Metformin/TZD a 3 month study and really looking at the efficacy in Typell Diabetes. ----Our second Phasell Study would be G1 plus Byetta and we are now in discussions with a few partners that are interested in these technologies to see how we might move these forward together. ----We are Initiating a G1 and a GLP1-INT Phasell clinical trials. We are submitting, actually, a Protocol right now to the FDA to Initiate or start discussions Initiating these programs and at the same time we are looking at potential partners who are experts in these areas to work with us and move these programs forward.
Bullboard Posts